SYMPTOM IMPROVEMENT ASSOCIATED WITH LURASIDONE TREATMENT OF CHILDREN AND ADOLESCENTS WITH BIPOLAR I DEPRESSION: RESULTS OF A SHORT-TERM PLACEBO-CONTROLLED TRIAL

被引：1
|
作者：
Singh, Manpreet K. [1 ]
Goldman, Robert [2 ]
Tocco, Michael [2 ]
Pikalov, Andrei A. [2 ]
Deng, Ling [2 ]
Cucchiaro, Josephine [2 ]
Loebel, Antony [2 ]
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] Sunovion Pharmaceut Inc, Marlborough, MA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY | 2017年 / 56卷 / 10期
关键词：
D O I：
10.1016/j.jaac.2017.09.333
中图分类号：
B844 [发展心理学（人类心理学）];
学科分类号：
040202 ;
摘要：
5.50
引用
收藏
页码：S271 / S272
页数：3
相关论文
共 50 条
  • [41] A DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL OF ADJUNCTIVE ARMODAFINIL FOR THE TREATMENT OF MAJOR DEPRESSION ASSOCIATED WITH BIPOLAR I DISORDER
    Frye, M. A.
    Ketter, T. A.
    Yang, R.
    Calabrese, J. R.
    VALUE IN HEALTH, 2013, 16 (03) : A55 - A56
  • [42] A double-blind, placebo-controlled, multicenter trial of adjunctive armodafinil for the treatment of major depression associated with bipolar I disorder
    Ketter, T. A.
    Calabrese, J. R.
    Yang, R.
    Frye, M. A.
    BIPOLAR DISORDERS, 2013, 15 : 88 - 88
  • [43] Lurasidone in the treatment of schizophrenia: Results of a double-blind, placebo-controlled trial in Asian patients
    Higuchi, Teruhiko
    Ishigooka, Jun
    Iyo, Masaomi
    Yeh, Chin-Bin
    Ebenezer, Esther Gunaseli
    Liang, Kuei Yu
    Lee, Jung Sik
    Lee, Sang Yeol
    Lin, Shih Ku
    Yoon, Bo-Hyun
    Nakamura, Masatoshi
    Hagi, Katsuhiko
    Sato, Takayuki
    ASIA-PACIFIC PSYCHIATRY, 2019, 11 (02)
  • [44] Lurasidone monotherapy in the treatment of bipolar I depression: Safety and tolerability Results of a randomized, double-blind, placebo-controlled, 6-week elevate study
    Kato, T.
    Ishigooka, J.
    Masuda, T.
    Watabe, K.
    Fujimori, T.
    Higuchi, T.
    BIPOLAR DISORDERS, 2019, 21 : 131 - 131
  • [45] EFFECT OF LURASIDONE ON WEIGHT AND METABOLIC PARAMETERS: RESULTS FROM POOLED SHORT-TERM PLACEBO-CONTROLLED AND LONG-TERM EXTENSION TRIALS IN SCHIZOPHRENIA
    Pikalov, Andrei
    Cucchiaro, Josephine
    Ogasa, M.
    Silva, Robert
    Hsu, J.
    Xu, J.
    Loebel, Antony
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 317 - 317
  • [46] LURASIDONE IN THE TREATMENT OF ACUTE SCHIZOPHRENIA: RESULTS OF THE DOUBLE-BLIND, PLACEBO-CONTROLLED PEARL 2 TRIAL
    Cucchiaro, Josephine
    Silva, Robert
    Ogasa, Masaaki
    Xu, Jane
    Phillips, Debra
    Simonelli, Doreen
    Kalali, Amir
    Loebel, Antony
    Meltzer, Herbert
    SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 493 - 493
  • [47] LURASIDONE IN THE TREATMENT OF ACUTE SCHIZOPHRENIA: RESULTS OF THE DOUBLE-BLIND, PLACEBO-CONTROLLED PEARL 2 TRIAL
    Meltzer, Herbert Y.
    Cucchiaro, Josephine
    Silva, R.
    Ogasa, M.
    Phillips, D.
    Xu, J.
    Kalali, A. H.
    Loebel, A.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 315 - 315
  • [48] Efficacy of Lurasidone in Patients With Schizophrenia With Prominent Positive Symptoms: A Pooled Analysis of Short-Term Placebo-Controlled Studies
    Potkin, Steven G.
    Tocco, Michael
    Mao, Yongcai
    Cucchiaro, Josephine
    Loebel, Antony
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 201 - 201
  • [49] Efficacy and safety of lurasidone in male and female patients with schizophrenia: a pooled analysis of short-term, placebo-controlled studies
    Perkins, D.
    Tocco, M.
    Pikalov, A.
    Hsu, J.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S569 - S569
  • [50] Lurasidone Adjunctive Therapy with Lithium or Valproate for the Treatment of Bipolar I Depression: A Randomized, Double-blind, Placebo-controlled Study (PREVAIL 3)
    Suppes, Trisha
    Calabrese, Joseph R.
    Silva, Robert
    Kroger, Hans
    Cucchiaro, Josephine
    Pikalov, Andrei
    Loebel, Antony
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S533 - S534
12345